Tildrakizumab: the Patient Journey

Those impacted know too well the challenges of living with moderate-to-severe plaque psoriasis. With recent treatment innovations, new biologic drugs like tildrakizumab (Ilumya), an interleukin-23 (IL-23) inhibitor, your symptoms can be successfully controlled and you can regain your quality of life. To start, it is important that you seek medical advice from your dermatologist. Achieving long-term clear skin is possible with the right treatment!

This video contents:

Back to First Video

IL-23s: Psoriasis therapy overview

Long-term use of interleukin-23 (IL-23) psoriasis therapies
This physician-led video initiative explores community experience with the long-term use and effect of interleukin-23 (IL-23) psoriasis therapies.